Table 2. General characteristics of MK- group and MK+ group.
| Characteristic | MK- group, n=510 (%) | MK+ group, n=119 (%) | P |
|---|---|---|---|
| Age, years | 0.455 | ||
| <70 | 409 (80.5) | 99 (19.5) | |
| ≥70 | 101 (83.5) | 20 (16.5) | |
| Gender | 0.014 | ||
| Male | 284 (77.8) | 81 (22.2) | |
| Female | 226 (85.6) | 38 (14.4) | |
| Histological type | 0.005 | ||
| SCC | 109 (76.8) | 33 (23.2) | |
| NSCC | 371 (84.1) | 70 (15.9) | |
| Others | 30 (66.7) | 15 (33.3) | |
| Size, cm | 0.062 | ||
| <3 | 238 (84.7) | 43 (15.3) | |
| 3–5 | 156 (80.8) | 37 (19.2) | |
| 5–7 | 74 (75.5) | 24 (24.5) | |
| ≥7 | 35 (71.4) | 14 (28.6) | |
| pN stage | 0.097 | ||
| pN0 | 303 (80.2) | 75 (19.8) | |
| pN1 | 63 (75.0) | 21 (25.0) | |
| pN2 | 120 (86.3) | 19 (13.7) | |
| Chemotherapy | 0.097 | ||
| Yes | 270 (78.7) | 73 (21.3) | |
| No | 240 (83.9) | 46 (16.1) |
SCC, squamous cell carcinoma; NSCC, non-SCC; MK, megakaryocyte.